It is September once again, time for us to review the state of the anti-inflammatory landscape in the world of dry eye disease.
Boy, it sure seems like I have done a lot of these things. You might think that there is not a whole lot more to say, and in some ways, I would agree. But as sure as the wind quickens here on the North Coast and the temperatures become more bracing, it looks like this part of the dry eye disease (DED) world has seen enough meaningful (Read more...)